Right ventricular outflow reconstruction with homografts

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Thoracic Surgery

Background:

• Right ventricular outflow tract (RVOT) reconstruction is crucial for complex congenital heart disease.
• Homografts are utilized for RVOT repair, but their long-term efficacy requires evaluation.
• Cryopreserved homografts offer a potential solution for RVOT reconstruction.

Purpose of the Study:

• To evaluate the medium-term performance of cryopreserved homografts in RVOT reconstruction.
• To compare outcomes in patients with ventriculo-arterial (VA) concordance, VA discordance, and truncus arteriosus.
• To assess the suitability of pulmonary homografts in specific RVOT defect types.

Main Methods:

• Retrospective analysis of 90 pediatric and young adult patients undergoing RVOT reconstruction with aortic or pulmonary homografts.
• Patients categorized into three groups: VA concordance, VA discordance, and truncus arteriosus.
• Follow-up included echocardiography to assess gradients and regurgitation, and clinical evaluation for functional status.

Main Results:

• Low hospital mortality (1.1%) with excellent medium-term functional outcomes (NYHA classes I-II) for most patients.
• Significant gradients were observed in 4% (concordant), 28% (discordant), and 18% (truncus arteriosus) of patients.
• Moderate pulmonary regurgitation was noted in 24% (concordant) and 13% (discordant) of cases.

Conclusions:

• Cryopreserved homografts demonstrate excellent medium-term performance in pediatric and young adult RVOT reconstruction.
• Pulmonary homografts are particularly effective in VA concordant lesions.
• Patients with VA discordance require vigilant follow-up due to higher incidence of complications.